Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights Life Science Investing
Atea Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call on May 14, 2024 Life Science Investing
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635 Life Science Investing
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635 Life Science Investing
Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights Life Science Investing
Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates Life Science Investing
Galecto Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with Pembrolizumab Life Science Investing
BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
